Stay updated on MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Sign up to get notified when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.

Latest updates to the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is a site version update and the temporary funding-status notice was removed. No substantive changes were made to the study data, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check21 days agoChange DetectedAn administrative notice about lapse in government funding was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary option is now visible to help users understand technical terms. Meta labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision version updated to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedPage footer shows a revision update: v3.3.3 was replaced by v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated the Publications note to say publications are provided voluntarily by the person who enters information about the study and are about the results of the study, and added Revision: v3.3.2. Removed the older Publications note phrasing and the Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.